Health condition
Fragile X premutation (FXTAS)
Carriers of a fragile X premutation - 55 to 200 CGG repeats in the FMR1 gene - can develop FXTAS, a late-onset tremor and balance disorder, most often in men over 50, frequently misdiagnosed as Parkinson's disease or essential tremor.
Why trust this guide
- 01
Editorial team
Written by our editorial team from the UK sources listed on each page.
- 02
Sourced from guidance
Checked against current NHS and UK specialist society guidance at the time of review.
- 03
Current for 2026
Reviewed on 2026-09-27 with the next review scheduled for 2027-09-27.
Key facts
The essentials at a glance.
Which gene and test confirm it, who should be tested in the family, and which specialist to see.
-
FXTAS affects premutation carriers, not people with full-mutation fragile X syndrome; risk rises with age - roughly 40% of male carriers over 50 develop it, fewer women
-
Features: intention tremor, gait ataxia, cognitive and memory changes, neuropathy and autonomic symptoms; MRI often shows a characteristic signal in the middle cerebellar peduncles
-
The clue is often in the family: a grandfather with tremor whose grandchild has fragile X syndrome, or a daughter with early menopause
-
Diagnosis: FMR1 repeat-size testing (a specific test - standard gene panels can miss repeat expansions)
Understanding the condition
What it is and what happens next.
What causes it, how it is confirmed, and the testing and specialist routes available in the UK.
What it is and how it presents
FXTAS was only recognised in 2001, which helps explain how often it is still missed: an older man develops shaking hands and unsteady walking, receives a Parkinson's or essential tremor label, responds poorly to treatment - and no one asks whether a grandchild has learning disability or a daughter went through menopause at 35. The premutation sits silently in roughly 1 in 800 men and 1 in 250 women, and its late neurological expression follows a different mechanism from fragile X syndrome itself, driven by toxic excess FMR1 messenger RNA rather than gene silencing.
Testing, surveillance and specialist care
An FMR1 repeat analysis - a targeted blood test - settles the question, and while treatment remains symptomatic, the diagnosis redirects management, ends futile therapeutic trials and carries major family information: daughters of male carriers all inherit the premutation, with implications for their children and their own ovarian health, best worked through with genetic counselling. NHS clinical genetics services carry some of the longest waits in the health service, often many months for a first appointment, whereas private genetic testing and a specialist review can typically be arranged within around two weeks.
Seeing a specialist
Who to see, and how quickly you can be seen.
The specialist for this condition is usually a neurologist working with clinical genetics. Your GP can refer you on the NHS, or you can arrange a private consultation directly.
A quiet reminder
This guide is for information, not medical advice.
Your GP knows your history and can tell you which parts apply to you. If in doubt, see them - and seek urgent care for any emergency symptoms.
Frequently asked
Common questions about Fragile X premutation (FXTAS).
Quick, plain-English answers to what people ask us most.
-
Can you explain what fragile X premutation (FXTAS) is?
Fragile X premutation (FXTAS) refers to a recognised clinical condition that a GP or specialist assesses using your history, examination and, if appropriate, targeted investigations. The way it presents and its impact can vary considerably from person to person.
-
What causes fragile X premutation (FXTAS)?
The exact cause of fragile X premutation (FXTAS) can involve a mix of genetic, environmental and lifestyle factors, and it isn't always possible to pin down a single trigger. A specialist assessment can help identify any modifiable risk factors relevant to you.
-
What does fragile X premutation (FXTAS) look like?
Symptoms of fragile X premutation (FXTAS) vary from person to person and can range from mild and easily missed to significant enough to affect daily life. Because overlapping conditions can produce similar symptoms, a clinical assessment is the most reliable way to confirm what's actually going on.
-
Is fragile X premutation (FXTAS) serious or dangerous?
Most cases of fragile X premutation (FXTAS) are manageable with appropriate care, though, like many conditions, it can occasionally lead to complications if left unassessed or untreated. Your clinician can give you a realistic sense of the risks based on your specific presentation.
-
Does fragile X premutation (FXTAS) run in families?
Many forms of fragile X premutation (FXTAS) have a genetic or inherited component, and some are linked to specific gene changes that can run in families. If there's a family history, genetic counselling can help clarify the pattern of inheritance and whether relatives might benefit from testing.
-
Can fragile X premutation (FXTAS) be treated or prevented?
Fragile X premutation (FXTAS) can often be managed effectively, and in some cases prevented or reversed, with the right combination of lifestyle changes, medication or other targeted treatment. A specialist will tailor the approach to your circumstances rather than applying a one-size-fits-all plan.
-
What treatment options are available for fragile X premutation (FXTAS)?
Management of fragile X premutation (FXTAS) is individualised, ranging from conservative measures and monitoring through to more active medical or surgical treatment depending on how it's affecting you. A clear diagnosis is the first step towards choosing the right approach.
-
How long does fragile X premutation (FXTAS) last?
The outlook for fragile X premutation (FXTAS) varies widely depending on the underlying cause, how early it's diagnosed, and how it responds to treatment. Many people see significant improvement with appropriate care, and your specialist can give you a more personalised timeframe once they've reviewed your case.
-
What else could fragile X premutation (FXTAS) be mistaken for?
Because several conditions can share similar symptoms to fragile X premutation (FXTAS), clinicians often consider a short list of possibilities before confirming a diagnosis. This is one of the main reasons a proper assessment, and sometimes targeted tests, matters more than relying on symptoms alone.
-
When should I see a doctor about fragile X premutation (FXTAS), and how quickly can I be seen privately?
It's worth seeking medical advice if symptoms of fragile X premutation (FXTAS) are persistent, worsening, or affecting your daily life, rather than waiting for them to resolve on their own. NHS routine referrals for this kind of assessment can take anywhere from around 20 to 45+ weeks, whereas private consultants typically offer an appointment within about two weeks.